RecruitingNCT06451029

Prevention of Smoking Related Diseases

Integrated Primary and Secondary Prevention of Smoking Related Diseases With Low Dose CT Scan and Circulating Biomarkers, Coupled With Personalised Smoking Cessation Activity


Sponsor

Scientific Institute San Raffaele

Enrollment

189 participants

Start Date

Jan 11, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

This is a prospective, observational, monocentric study. This study wants to test if among a smoking cessation intervention, behavioural counselling by video session is related to higher compliance and higher success rate than standard smoking cessation activity (face to face counselling).


Eligibility

Min Age: 50 Years

Plain Language Summary

Simplified for easier understanding

This study aims to prevent diseases caused by smoking — such as lung cancer, heart disease, and emphysema — in people who have been heavy smokers for many years. Researchers are testing preventive strategies in long-term smokers who are open to quitting. **You may be eligible if...** - You are 50 years of age or older - You are a heavy smoker with 20 or more pack-years (e.g., 1 pack per day for 20 years, or 2 packs per day for 10 years) - You are willing to sign an informed consent form **You may NOT be eligible if...** - You have no plans to quit smoking Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Scientific Institute Ospedale San Raffaele

Milan, Italy, Milan, Italy

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06451029


Related Trials